Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue
Launched by FACULDADE DE MEDICINA DO ABC · Jan 6, 2010
Trial Information
Current as of June 04, 2025
Completed
Keywords
ClinConnect Summary
The aim of this study is evaluate the favourable effects of Guaraná in quality of life and Fatigue in patients undergoing Chemotherapy treatment for Breast Cancer. After approval by our Institutional Review Board, we included consenting patients with a histological diagnosis of Breast Cancer for whom Chemotherapy was indicated.
Patients who agreed to participate in the study were submitted initially to a screening interview with the Brief Fatigue Inventory questionnaire from MD Anderson. If the patient presented with a severe fatigue, anemia (HB\<11.0), hypothyroidism or psychiatric disord...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Histological diagnosis of Breast Cancer
- • Patients undergoing Chemotherapy (First Cycle)
- • 18 years old or older
- Exclusion Criteria:
- • Hypothyroidism
- • Clinical Depression
- • Prior Chemotherapy
- • Anemia
- • Unable to sign informed consent
- • Severe Fatigue
About Faculdade De Medicina Do Abc
Faculdade de Medicina do ABC is a prestigious medical institution located in São Paulo, Brazil, dedicated to advancing healthcare through education, research, and clinical practice. Renowned for its commitment to excellence in medical training and innovation, the institution actively sponsors clinical trials aimed at evaluating new treatments and interventions across various medical fields. By fostering collaboration between healthcare professionals and researchers, Faculdade de Medicina do ABC seeks to enhance patient outcomes and contribute to the global body of medical knowledge. Its rigorous ethical standards and comprehensive approach ensure that all clinical studies are conducted with the utmost integrity and scientific validity.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Santo Andre, Sp, Brazil
Patients applied
Trial Officials
Auro D Giglio, MD, PhD
Study Director
Faculdade de Medicina do ABC
Maira P Oliveira Campos, MD
Principal Investigator
Faculdade de Medicina do ABC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials